Unlocking potential of oxytocin: improving intracranial lymphatic drainage for Alzheimer's disease treatment

The impediment to β-amyloid (Aβ) clearance caused by the invalid intracranial lymphatic drainage in Alzheimer's disease is pivotal to its pathogenesis, and finding reliable clinical available solutions to address this challenge remains elusive.